These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 27399677

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
    Nachliely M, Trachtenberg A, Khalfin B, Nalbandyan K, Cohen-Lahav M, Yasuda K, Sakaki T, Kutner A, Danilenko M.
    J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Involvement of microRNA181a in differentiation and cell cycle arrest induced by a plant-derived antioxidant carnosic acid and vitamin D analog doxercalciferol in human leukemia cells.
    Duggal J, Harrison JS, Studzinski GP, Wang X.
    Microrna; 2012 Apr; 1(1):26-33. PubMed ID: 25048087
    [Abstract] [Full Text] [Related]

  • 7. Cooperative antiproliferative and differentiation-enhancing activity of medicinal plant extracts in acute myeloid leukemia cells.
    Zhamanbayeva GT, Aralbayeva AN, Murzakhmetova MK, Tuleukhanov ST, Danilenko M.
    Biomed Pharmacother; 2016 Aug; 82():80-9. PubMed ID: 27470342
    [Abstract] [Full Text] [Related]

  • 8. Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.
    Shabtay A, Sharabani H, Barvish Z, Kafka M, Amichay D, Levy J, Sharoni Y, Uskokovic MR, Studzinski GP, Danilenko M.
    Oncology; 2008 Aug; 75(3-4):203-14. PubMed ID: 18852491
    [Abstract] [Full Text] [Related]

  • 9. Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium.
    Danilenko M, Wang Q, Wang X, Levy J, Sharoni Y, Studzinski GP.
    Cancer Res; 2003 Mar 15; 63(6):1325-32. PubMed ID: 12649194
    [Abstract] [Full Text] [Related]

  • 10. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
    Asou H, Koike M, Elstner E, Cambell M, Le J, Uskokovic MR, Kamada N, Koeffler HP.
    Blood; 1998 Oct 01; 92(7):2441-9. PubMed ID: 9746784
    [Abstract] [Full Text] [Related]

  • 11. Biological Evaluation of Double Point Modified Analogues of 1,25-Dihydroxyvitamin D₂ as Potential Anti-Leukemic Agents.
    Corcoran A, Nadkarni S, Yasuda K, Sakaki T, Brown G, Kutner A, Marcinkowska E.
    Int J Mol Sci; 2016 Feb 01; 17(2):. PubMed ID: 26840307
    [Abstract] [Full Text] [Related]

  • 12. The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells.
    Bobilev I, Novik V, Levi I, Shpilberg O, Levy J, Sharoni Y, Studzinski GP, Danilenko M.
    Cancer Biol Ther; 2011 Feb 01; 11(3):317-29. PubMed ID: 21099366
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
    Wang X, Harrison JS, Studzinski GP.
    J Steroid Biochem Mol Biol; 2016 Nov 01; 164():72-78. PubMed ID: 26319201
    [Abstract] [Full Text] [Related]

  • 14. Studies on the mechanisms of superagonistic pro-differentiating activities of side-chain modified analogs of vitamin D2.
    Baurska H, Marchwicka A, Kłopot A, Kutner A, Marcinkowska E.
    Oncol Rep; 2012 Sep 01; 28(3):1110-6. PubMed ID: 22751936
    [Abstract] [Full Text] [Related]

  • 15. Antiproliferative Activity and in Vivo Toxicity of Double-Point Modified Analogs of 1,25-Dihydroxyergocalciferol.
    Trynda J, Turlej E, Milczarek M, Pietraszek A, Chodyński M, Kutner A, Wietrzyk J.
    Int J Mol Sci; 2015 Oct 20; 16(10):24873-94. PubMed ID: 26492238
    [Abstract] [Full Text] [Related]

  • 16. Different susceptibilities to 1,25-dihydroxyvitamin D3-induced differentiation of AML cells carrying various mutations.
    Gocek E, Kiełbiński M, Baurska H, Haus O, Kutner A, Marcinkowska E.
    Leuk Res; 2010 May 20; 34(5):649-57. PubMed ID: 19880182
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, CYP24A1-Dependent Metabolism and Antiproliferative Potential against Colorectal Cancer Cells of 1,25-Dihydroxyvitamin D2 Derivatives Modified at the Side Chain and the A-Ring.
    Milczarek M, Chodyński M, Pietraszek A, Stachowicz-Suhs M, Yasuda K, Sakaki T, Wietrzyk J, Kutner A.
    Int J Mol Sci; 2020 Jan 18; 21(2):. PubMed ID: 31963716
    [Abstract] [Full Text] [Related]

  • 18. Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance.
    Chen-Deutsch X, Studzinski GP.
    Cell Cycle; 2012 Apr 01; 11(7):1364-73. PubMed ID: 22421156
    [Abstract] [Full Text] [Related]

  • 19. Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid.
    Steiner M, Priel I, Giat J, Levy J, Sharoni Y, Danilenko M.
    Nutr Cancer; 2001 Apr 01; 41(1-2):135-44. PubMed ID: 12094616
    [Abstract] [Full Text] [Related]

  • 20. [Enhancement of differentiation induction of HL-60 cells by 1,25-dihydroxyvitamin D3 in combination with carnosic acid].
    Ren LH, Chen JJ, An HP.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb 01; 10(1):55-9. PubMed ID: 18289473
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.